Oscar Health COO Meghan Joyce resigns effective April 10, 2022; +Oscar platform reports to CEO Schlosser

Oscar Health, Inc.

COO Meghan Joyce resigns effective April 10, 2022 to become CEO of a new venture; she will serve as Senior Advisor for 2 years.
+Oscar technology platform will report directly to co-founder/CEO Mario Schlosser; insurance operations to Chief Insurance Officer Alessandrea Quane.
Consulting fee of $8,333/month for 2 years; vested stock options remain exercisable during consulting period; unvested awards forfeited.
No annual bonus for 2022; if terminated without cause, severance includes up to 6 months of fees and extended option exercisability.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Meghan Joyce

Chief Operating Officer

OSCR · Oscar Health, Inc.

Effective: 2022-04-10
Filed: March 8, 2022, 6:59 PM ET

On March 7, 2022, Meghan Joyce notified Oscar Heath, Inc. (the “Company”) that she is resigning effective on April 10, 2022 after a successful tenure as the Chief Operating Officer and Executive Vice President of Platform to be the CEO of a new venture.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Meghan Joyce resigned as Chief Operating Officer at Oscar Health, Inc..

Action: resigned
Role: Chief Operating Officer

Exact text from the filing

On March 7, 2022, Meghan Joyce notified Oscar Heath, Inc. (the “Company”) that she is resigning effective on April 10, 2022 after a successful tenure as the Chief Operating Officer and Executive Vice President of Platform to be the CEO of a new venture.

View on SEC.gov

Oscar Health, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-069272

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.